The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: MDS Analytical Technologies

Monday Biotech Deal Review: February 1, 2010

Canadian biotech companies were busy making and closing deals this week, with $44 million raised, four new licensing and collaboration deals, and particularly big weeks for Ospens and the MDS/Dahaner transaction. Read more of this post

Monday Biotech Deal Review: October 25, 2009

B&W_BigNickelA very busy deal week coincided with a very busy work week (for those of us with day jobs), so allow me a particularly grateful thank-you to Jacob Cawker, who’s been an invaluable help with the Deal Review this and the last several weeks.  After the jump, licenses both inbound, outbound and just tied up (optioned); securities extended and accelerated (plus an actual common share offering, with the word “units” banished for one special week); and last but not least, a good volume of Canadian M&A (M&Eh?) from private to public to “just browsing.”  Read more of this post

Monday Biotech Deal Review: October 12, 2009

Here’s the roundup for today. It’s the Canadian Thanksgiving weekend, but there’s not a turkey in the bunch.  Read more of this post

MDS Files Proxy Circular for Sale of Analytical Technologies Business to Danaher

If you wanted more details of MDS’ deal to sell its analytical technologies business to Danaher, today is your lucky day.  The management proxy circular for the shareholders’ meeting to vote on the deal was filed on EDGAR and SEDAR.  Here’s a direct link to the EDGAR filing.

Bookmark and Share


Get every new post delivered to your Inbox.

Join 128 other followers